PMS2 and neoplasm: An algorithm for predicting tumor MSI status by detecting loss of expression in the four MMR genes MLH1, MSH2, MSH6 and PMS2 was developed using the TCGA datasets for the 3 tumor types known to have relatively high prevalence of MSI-H status (i.e. colon, endometrial and gastric cancers).